Antibody–Drug Conjugates for the Treatment of Non-Small Cell Lung Cancer with Central Nervous System Metastases

Antibody–drug conjugates (ADCs) represent an emerging class of targeted anticancer agents that have demonstrated impressive efficacy in numerous cancer types. In non-small cell lung cancer (NSCLC), ADCs have become a component of the treatment armamentarium for a subset of patients with metastatic d...

Popoln opis

Bibliografske podrobnosti

Principais autores:	David J. H. Bian, Sara F. Cohen, Anna-Maria Lazaratos, Nathaniel Bouganim, Matthew Dankner
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2024-10-01
Serija:	Current Oncology
Teme:	brain metastasis central nervous system metastasis non-small-cell lung cancer lung cancer antibody–drug conjugate ADC
Online dostop:	https://www.mdpi.com/1718-7729/31/10/471
Oznake:	Označite Brez oznak, prvi označite!